ZA969586B - The use of cholinesterase inhibitors in the treatment of xerostomia - Google Patents

The use of cholinesterase inhibitors in the treatment of xerostomia

Info

Publication number
ZA969586B
ZA969586B ZA969586A ZA969586A ZA969586B ZA 969586 B ZA969586 B ZA 969586B ZA 969586 A ZA969586 A ZA 969586A ZA 969586 A ZA969586 A ZA 969586A ZA 969586 B ZA969586 B ZA 969586B
Authority
ZA
South Africa
Prior art keywords
xerostomia
treatment
cholinesterase inhibitors
cholinesterase
inhibitors
Prior art date
Application number
ZA969586A
Other languages
English (en)
Inventor
Joergen Ekstroem
Herbert Helander
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA969586B publication Critical patent/ZA969586B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA969586A 1995-11-29 1996-11-14 The use of cholinesterase inhibitors in the treatment of xerostomia ZA969586B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9504267A SE9504267D0 (sv) 1995-11-29 1995-11-29 New therapeutic use

Publications (1)

Publication Number Publication Date
ZA969586B true ZA969586B (en) 1997-05-29

Family

ID=20400405

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969586A ZA969586B (en) 1995-11-29 1996-11-14 The use of cholinesterase inhibitors in the treatment of xerostomia

Country Status (14)

Country Link
US (1) US5962503A (xx)
EP (1) EP0866699B1 (xx)
JP (1) JP4113257B2 (xx)
CN (2) CN1207679A (xx)
AR (1) AR004330A1 (xx)
AT (1) ATE216235T1 (xx)
AU (1) AU718661B2 (xx)
DE (1) DE69620786T2 (xx)
DK (1) DK0866699T3 (xx)
ES (1) ES2175153T3 (xx)
PT (1) PT866699E (xx)
SE (1) SE9504267D0 (xx)
WO (1) WO1997019685A1 (xx)
ZA (1) ZA969586B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102403A1 (en) * 2001-06-14 2002-12-27 Novo Nordisk A/S Mucosal repair by tff dimer peptides
JP2006070027A (ja) * 2004-08-06 2006-03-16 Dai Ichi Seiyaku Co Ltd 口腔粘膜投与剤
US20060263414A1 (en) * 2005-05-19 2006-11-23 Pauline Pan Confectionery products for the treatment of dry mouth
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
US20090053309A1 (en) * 2007-08-24 2009-02-26 Axiomedic Ltd., Gibraltar Adhesive compositions for the treatment of xerostomia
US9161909B2 (en) * 2007-08-24 2015-10-20 Axiomedic Ltd. Adhesive compositions for the treatment of xerostomia
CN114010575B (zh) * 2021-10-22 2024-06-28 江苏谛奇医药科技有限公司 新斯的明及其衍生物的新制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187165A (en) * 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
SE9103752D0 (sv) * 1991-12-18 1991-12-18 Astra Ab New compounds
US5387614A (en) * 1993-07-27 1995-02-07 University Of Iowa Research Foundation Use of sigma receptor ligands as salivary gland stimulants

Also Published As

Publication number Publication date
JP2000508618A (ja) 2000-07-11
DK0866699T3 (da) 2002-08-12
CN101380320A (zh) 2009-03-11
ATE216235T1 (de) 2002-05-15
DE69620786T2 (de) 2002-11-21
US5962503A (en) 1999-10-05
WO1997019685A1 (en) 1997-06-05
AU718661B2 (en) 2000-04-20
EP0866699B1 (en) 2002-04-17
DE69620786D1 (de) 2002-05-23
AU7716096A (en) 1997-06-19
SE9504267D0 (sv) 1995-11-29
EP0866699A1 (en) 1998-09-30
CN101380320B (zh) 2010-12-29
ES2175153T3 (es) 2002-11-16
JP4113257B2 (ja) 2008-07-09
CN1207679A (zh) 1999-02-10
AR004330A1 (es) 1998-11-04
PT866699E (pt) 2002-08-30

Similar Documents

Publication Publication Date Title
CY2006007I1 (el) Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας
GB2298422B (en) Compounds and their use
GB2298440B (en) Well treatment
GB9506926D0 (en) Cystine-siicone copolymers and their use for treating keratin substrates
GB9526546D0 (en) Compounds useful in therapy
GB2304196B (en) Electroconvulsive therapy
EP0831800A4 (en) ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THEIR USE AS FACTOR Xa INHIBITORS
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
IL122813A0 (en) Thrombin inhibitors their preparation and use
GB9526560D0 (en) Use of 2-Amino-Heterocycles
AP2000001796A0 (en) The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
GB9519033D0 (en) Treatment
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
AU9052991A (en) Use of angiotensin ii antagonist in the treatment of infarction
ZA96725B (en) Use of phenyclyclohexylcarboxamides
ZA969586B (en) The use of cholinesterase inhibitors in the treatment of xerostomia
ZA965191B (en) Cell treatment
EP0840605A4 (en) COMPOUNDS FOR USE IN THE TREATMENT OF NEUROFIBROMATOSE
GB2309979B (en) Diamond treatment
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9523066D0 (en) Compounds and their therapeutic use
GB9511583D0 (en) Compounds useful in therapy
GB9511585D0 (en) Compounds useful in therapy
GB9523135D0 (en) Compounds useful in therapy
GB9504627D0 (en) Compounds for use in therapy